ZA959729B - Immunogenic compositions - Google Patents

Immunogenic compositions

Info

Publication number
ZA959729B
ZA959729B ZA959729A ZA959729A ZA959729B ZA 959729 B ZA959729 B ZA 959729B ZA 959729 A ZA959729 A ZA 959729A ZA 959729 A ZA959729 A ZA 959729A ZA 959729 B ZA959729 B ZA 959729B
Authority
ZA
South Africa
Prior art keywords
immunogenic compositions
immunogenic composition
solubilised
immunogen
absence
Prior art date
Application number
ZA959729A
Other languages
English (en)
Inventor
Roger Randal Charles New
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of ZA959729B publication Critical patent/ZA959729B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA959729A 1994-11-15 1995-11-15 Immunogenic compositions ZA959729B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9422990A GB9422990D0 (en) 1994-11-15 1994-11-15 Immunogenic compositions

Publications (1)

Publication Number Publication Date
ZA959729B true ZA959729B (en) 1997-05-15

Family

ID=10764393

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA959729A ZA959729B (en) 1994-11-15 1995-11-15 Immunogenic compositions

Country Status (19)

Country Link
EP (1) EP0792165B1 (no)
JP (1) JP4297515B2 (no)
KR (1) KR970706848A (no)
CN (1) CN100346828C (no)
AT (1) ATE249841T1 (no)
AU (1) AU700910B2 (no)
CA (1) CA2205083A1 (no)
DE (1) DE69531793T2 (no)
DK (1) DK0792165T3 (no)
ES (1) ES2210318T3 (no)
FI (1) FI972054A0 (no)
GB (1) GB9422990D0 (no)
IL (1) IL116010A0 (no)
MX (1) MX9703480A (no)
NO (1) NO972219L (no)
NZ (1) NZ295238A (no)
PT (1) PT792165E (no)
WO (1) WO1996014871A1 (no)
ZA (1) ZA959729B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323588D0 (en) 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
US6165773A (en) * 1995-10-25 2000-12-26 Provalis Uk Limited Methods of preserving viruses
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
AU736038C (en) * 1997-07-10 2006-08-10 Intervet Australia Pty Limited Non-aqueous vaccines
AR013202A1 (es) * 1997-07-10 2000-12-13 Biotech Australia Pty Ltd Vacunas no acuosas
ES2226338T3 (es) * 1998-02-12 2005-03-16 Wyeth Holdings Corporation Vacuna que comprenden interleucina 12 y antigeno del virus del herpes simple.
AU2596699A (en) * 1998-02-12 1999-08-30 American Cyanamid Company Vaccines comprising interleukin-12 and respiratory syncytial viral antigens
JP2002502882A (ja) * 1998-02-12 2002-01-29 アメリカン・サイアナミド・カンパニー インターロイキン−１２とともに処方された肺炎球菌および髄膜炎菌のワクチン
WO1999056776A2 (en) * 1998-05-07 1999-11-11 Corixa Corporation Adjuvant composition and methods for its use
CN1230184C (zh) 1998-07-16 2005-12-07 东市郎 以细菌的菌体成分为有效成分的癌免疫治疗用制剂
EP2197497B1 (en) 2007-09-27 2016-06-01 ImmunoVaccine Technologies Inc. Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
CA2700828C (en) * 2007-10-03 2017-01-24 Immunovaccine Technologies Inc. Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
EP2296696B1 (en) 2008-06-05 2014-08-27 ImmunoVaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
CN103517714A (zh) * 2010-12-23 2014-01-15 英珀特疗法有限公司 用于刚地弓形虫感染和弓形体病的诊断和治疗的方法和蛋白抗原组合物
GB201107629D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
CN102277373B (zh) * 2011-08-15 2014-07-02 南京大学 一种减毒沙门氏菌分泌表达的日本血吸虫疫苗表达载体及其应用
CN103998058B (zh) 2011-10-06 2021-11-05 免疫疫苗技术有限公司 包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
JP3609827B2 (ja) * 1991-06-26 2005-01-12 ヤマノウチ ユーロープ ベスローテン フェンノートシャップ 非極性基剤における小胞
DE69418334T2 (de) * 1993-08-06 2000-01-27 Opperbas Holding B.V., Amsterdam Verfahren zur hohen beladung von vesikeln mit biopolymeren substanzen
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation

Also Published As

Publication number Publication date
CN100346828C (zh) 2007-11-07
EP0792165B1 (en) 2003-09-17
ES2210318T3 (es) 2004-07-01
CN1163575A (zh) 1997-10-29
NZ295238A (en) 1999-01-28
AU3853495A (en) 1996-06-06
DE69531793D1 (de) 2003-10-23
NO972219D0 (no) 1997-05-14
GB9422990D0 (en) 1995-01-04
KR970706848A (ko) 1997-12-01
FI972054A (fi) 1997-05-14
MX9703480A (es) 1997-08-30
CA2205083A1 (en) 1996-05-23
NO972219L (no) 1997-07-11
JP4297515B2 (ja) 2009-07-15
WO1996014871A1 (en) 1996-05-23
EP0792165A1 (en) 1997-09-03
ATE249841T1 (de) 2003-10-15
DE69531793T2 (de) 2004-07-15
AU700910B2 (en) 1999-01-14
DK0792165T3 (da) 2004-01-05
FI972054A0 (fi) 1997-05-14
JPH10508834A (ja) 1998-09-02
IL116010A0 (en) 1996-01-31
PT792165E (pt) 2004-02-27

Similar Documents

Publication Publication Date Title
ZA959729B (en) Immunogenic compositions
WO1997001640A3 (en) Vaccines against hepatitis c
GR3025184T3 (en) Vaccine composition containing adjuvants.
AU2982889A (en) Novel dosage form of fenofibrate
CA2217178A1 (en) Vaccines containing a saponin and a sterol
AU4867697A (en) Oxadiazoles, processes for preparing them and their use as pharmaceutical compositions
MA22842A1 (fr) Procede de preparation de compositions de vaccin.
AU7546887A (en) Variants of lav viruses, their dna- and protein-components and their uses, particularly for diagnostic purposes and for the preparation of immunogenic compositions
AU6913687A (en) Solid antitartar mouth deodorant composition
CA2177668A1 (en) Mammalian vaccine compositions comprising squalene or squalane, glycerol and a surfactant as an adjuvant
AU4622693A (en) Potentiation of immunogenic response
DZ2283A1 (fr) Composition de vaccin.
IL98262A (en) Chromone derivatives and pharmaceutical compositions containing them
WO1997005899A3 (en) Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
CA2068431A1 (en) Stabilized stannous fluoride compositions for oral care
CA2216410A1 (en) Improved inactivated vaccines
NZ239281A (en) Antigenic hiv conjugate, vaccine and pharmaceutical composition
AU4450696A (en) Enhanced immunogenic vaccine
AU8204887A (en) Conjugate vaccine
HUP9903649A3 (en) Taxane derivatives, the preparation thereof and medical formulations containing them
AU2901997A (en) Immunogenic complex, use, method of preparation thereof and vaccine containing same
AU7528087A (en) Immunogenic fraction active against bilharzioses, its preparation, and immunizing compositions containing it
EP0385909A3 (en) A kit or composition for the prevention or treatment of HIV-1 infections
EG20082A (en) Process for preparing of octadecyl-(2-N-methylpiperidino)-ethyl-phosphate
AU7249491A (en) Improved immunogenic compositions